Frequencies for first 10,000 rows of drug5cl1 variable in nhamcsopd2003 dataset : drug class #1 for medication #5 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, local (injectable) | 28 0.28 0.28 anesthetics, general | 16 0.16 0.44 adjuncts to anesthesia/analeptics | 13 0.13 0.57 antidotes, specific | 3 0.03 0.60 antidotes, general | 1 0.01 0.61 penicillins | 10 0.10 0.71 cephalosporins | 14 0.14 0.85 erythromycins/lincosamides/macrolides | 5 0.05 0.90 tetracyclines | 1 0.01 0.91 aminoglycosides | 1 0.01 0.92 sulfonamides and trimethoprim | 1 0.01 0.93 urinary tract antiseptics | 2 0.02 0.95 miscellaneous antibacterial agents | 4 0.04 0.99 quinolones/derivatives | 1 0.01 1.00 antifungals | 1 0.01 1.01 antiviral agents | 9 0.09 1.10 deficiency anemias | 17 0.17 1.27 anticoagulants/thrombolytics | 18 0.18 1.45 cardiac glycosides | 7 0.07 1.52 antiarrhythmic agents | 6 0.06 1.58 antianginal agents | 15 0.15 1.73 vascular disorders, cerebral/peripheral | 5 0.05 1.78 antihypertensive agents | 50 0.50 2.28 diuretics | 43 0.43 2.71 relaxants/stimulants, urinary tract | 3 0.03 2.74 calcium channel blockers | 29 0.29 3.03 beta blockers | 31 0.31 3.34 alpha agonist/alpha blockers | 13 0.13 3.47 ace inhibitors | 36 0.36 3.83 central nervous system drugs, unspec... | 1 0.01 3.84 sedatives and hypnotics | 34 0.34 4.18 antianxiety agents | 19 0.19 4.37 antipsychotic/antimanics | 15 0.15 4.52 antidepressants | 56 0.56 5.08 anorexiants/cns stimulants | 2 0.02 5.10 alzheimer-type dementia | 1 0.01 5.11 antiemetics | 3 0.03 5.14 diagnostics, radiopaque & nonradioactiv | 1 0.01 5.15 disorders, acid/peptic | 56 0.56 5.71 antidiarrheals | 6 0.06 5.77 laxatives | 21 0.21 5.98 miscellaneous gastrointestinals | 2 0.02 6.00 antispasmodics/anticholinergics | 3 0.03 6.03 antacids | 8 0.08 6.11 hyperlipidemia | 49 0.49 6.60 vitamins/minerals | 39 0.39 6.99 nutrition, enteral/parenteral | 2 0.02 7.01 repl/regs of electrolytes/water balance | 29 0.29 7.30 calcium metabolism | 7 0.07 7.37 hematopoietic growth factor | 3 0.03 7.40 adrenal corticosteroids | 14 0.14 7.54 androgens/anabolic steroids | 5 0.05 7.59 estrogens/progestins | 14 0.14 7.73 blood glucose regulators | 46 0.46 8.19 thyroid/antithyroid | 25 0.25 8.44 contraceptives | 2 0.02 8.46 growth hormone secretion disorder | 1 0.01 8.47 vaccines/antisera | 29 0.29 8.76 immunomodulators | 8 0.08 8.84 dermatologics, misc. | 7 0.07 8.91 topical steroids | 6 0.06 8.97 acne products | 1 0.01 8.98 topical anti-infectives | 5 0.05 9.03 topical analgesics | 2 0.02 9.05 extrapyramidal movement disorders | 2 0.02 9.07 skeletal muscle hyperactivity | 10 0.10 9.17 anticonvulsants | 35 0.35 9.52 antineoplastics, miscellaneous | 5 0.05 9.57 hormonal/biological response mod. | 2 0.02 9.59 antimetabolites | 4 0.04 9.63 antibiotics,alkaloids,enzymes | 1 0.01 9.64 dna damaging drugs | 4 0.04 9.68 ophthalmic drugs, unspecified | 1 0.01 9.69 glaucoma | 2 0.02 9.71 cycloplegics/mydriatics | 1 0.01 9.72 ocular anti-infective/anti-inflammatory | 3 0.03 9.75 miscellaneous ophthalmics | 1 0.01 9.76 vertigo/motion sickness/vomiting | 13 0.13 9.89 analgesics/general | 2 0.02 9.91 analgesics, narcotic | 55 0.55 10.46 analgesics, non-narcotic | 60 0.60 11.06 antimigraine/other headaches | 2 0.02 11.08 antiarthritics | 13 0.13 11.21 antigout | 2 0.02 11.23 nsaid | 30 0.30 11.53 antiprotozoals | 3 0.03 11.56 antimalarials | 1 0.01 11.57 antiasthmatics/bronchodilators | 42 0.42 11.99 nasal decongestants | 2 0.02 12.01 antitussives/expectorants/mucolytics | 3 0.03 12.04 antihistamines | 21 0.21 12.25 corticosteroid-inhalation/nasal | 13 0.13 12.38 unclassified | 17 0.17 12.55 pharmaceutical aids | 1 0.01 12.56 homeopathic products | 7 0.07 12.63 . | 8,737 87.37 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016